Ecovyst (ECVT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $10.28, +1.08% vs the prior close of $10.17.
- Volume 1.69M shares, 1.3x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ECVT rises 1.1% to $10.28. Closed at $10.28, +1.08% vs the prior close of $10.17. Day range $10.06β$10.29, opened at $10.16.
ECVT daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β ECVT rises 1.1% to $10.28
- Closed at $10.28, +1.08% vs the prior close of $10.17. Day range $10.06β$10.29, opened at $10.16.
- Volume was 1.69M shares, 1.3x its 50-day average of 1.27M.
- Price is +0.7% vs its 50-day average ($10.21) and -13.1% vs its 200-day average ($11.83).
- 52-week range $7.41β$15.09; today's close sits at 37% of that range, 31.9% below the 52-week high.
Oct 15, 2026 β ECVT rises 2.5% to $10.17
- Closed at $10.17, +2.52% vs the prior close of $9.92. Day range $9.76β$10.19, opened at $9.90.
- Volume was 1.76M shares, 1.4x its 50-day average of 1.27M.
- Price is -0.5% vs its 50-day average ($10.22) and -14.0% vs its 200-day average ($11.83).
- 52-week range $7.41β$15.09; today's close sits at 36% of that range, 32.6% below the 52-week high.
Oct 14, 2026 β ECVT dips 1.6% to $9.92
- Closed at $9.92, -1.59% vs the prior close of $10.08. Day range $9.86β$10.08, opened at $9.98.
- Volume was 945.40K shares, 0.7x its 50-day average of 1.28M.
- Price is -3.2% vs its 50-day average ($10.25) and -16.1% vs its 200-day average ($11.83).
- 52-week range $7.41β$15.09; today's close sits at 33% of that range, 34.2% below the 52-week high.
Oct 13, 2026 β ECVT rises 1.6% to $10.08
- Closed at $10.08, +1.61% vs the prior close of $9.92. Day range $9.90β$10.13, opened at $9.97.
- Volume was 694.20K shares, 0.5x its 50-day average of 1.28M β lighter than usual.
- Price is -2.0% vs its 50-day average ($10.29) and -14.8% vs its 200-day average ($11.83).
- 52-week range $7.41β$15.09; today's close sits at 35% of that range, 33.2% below the 52-week high.
Oct 12, 2026 β ECVT dips 1.3% to $9.92, 5 down days in a row
- Closed at $9.92, -1.29% vs the prior close of $10.05. Day range $9.91β$10.09, opened at $10.09.
- Volume was 848.50K shares, 0.7x its 50-day average of 1.28M.
- Price is -4.0% vs its 50-day average ($10.33) and -16.1% vs its 200-day average ($11.82).
- 52-week range $7.41β$15.09; today's close sits at 33% of that range, 34.2% below the 52-week high.
- That makes 5 straight losses.
Oct 9, 2026 β ECVT dips 1.6% to $10.05, 4 down days in a row
- Closed at $10.05, -1.57% vs the prior close of $10.21. Day range $10.05β$10.23, opened at $10.18.
- Volume was 674.50K shares, 0.5x its 50-day average of 1.29M β lighter than usual.
- Price is -3.1% vs its 50-day average ($10.37) and -15.0% vs its 200-day average ($11.82).
- 52-week range $7.41β$15.09; today's close sits at 34% of that range, 33.4% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 β ECVT dips 1.0% to $10.21, 3 down days in a row
- Closed at $10.21, -0.97% vs the prior close of $10.31. Day range $10.12β$10.44, opened at $10.35.
- Volume was 1.60M shares, 1.3x its 50-day average of 1.28M.
- Price is -2.0% vs its 50-day average ($10.41) and -13.6% vs its 200-day average ($11.82).
- 52-week range $7.41β$15.09; today's close sits at 36% of that range, 32.3% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 β ECVT dips 0.6% to $10.31
- Closed at $10.31, -0.58% vs the prior close of $10.37. Day range $10.23β$10.38, opened at $10.34.
- Volume was 1.10M shares, 0.9x its 50-day average of 1.28M.
- Price is -1.3% vs its 50-day average ($10.45) and -12.8% vs its 200-day average ($11.82).
- 52-week range $7.41β$15.09; today's close sits at 38% of that range, 31.7% below the 52-week high.
Oct 6, 2026 β ECVT ends flat (+0.0%) to $10.37
- Closed at $10.37, +0.00% vs the prior close of $10.37. Day range $10.31β$10.50, opened at $10.46.
- Volume was 1.45M shares, 1.1x its 50-day average of 1.27M.
- Price is -1.1% vs its 50-day average ($10.49) and -12.2% vs its 200-day average ($11.81).
- 52-week range $7.41β$15.09; today's close sits at 39% of that range, 31.3% below the 52-week high.
Oct 5, 2026 β ECVT rises 2.5% to $10.37, 4 up days in a row
- Closed at $10.37, +2.47% vs the prior close of $10.12. Day range $10.09β$10.43, opened at $10.12.
- Volume was 1.03M shares, 0.8x its 50-day average of 1.27M.
- Price is -1.5% vs its 50-day average ($10.53) and -12.2% vs its 200-day average ($11.81).
- 52-week range $7.41β$15.09; today's close sits at 39% of that range, 31.3% below the 52-week high.
- That makes 4 straight gains.
Oct 2, 2026 β ECVT rises 1.6% to $10.12, 3 up days in a row
- Closed at $10.12, +1.61% vs the prior close of $9.96. Day range $10.03β$10.19, opened at $10.06.
- Volume was 1.08M shares, 0.8x its 50-day average of 1.28M.
- Price is -4.3% vs its 50-day average ($10.57) and -14.3% vs its 200-day average ($11.80).
- 52-week range $7.41β$15.09; today's close sits at 35% of that range, 32.9% below the 52-week high.
- That makes 3 straight gains.
ECVT latest news & SEC filings
Every SEC filing by or about ECVT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 14, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Humble Patti A. bought 24,875 shares at $10.05 (β$249.99K) on Sep 10, 2026
- Humble Patti A. bought 24,875 shares at $10.05 (β$249.99K) on Sep 10, 2026
- Humble Patti A. bought 24,875 shares at $10.05 (β$249.99K) on Sep 10, 2026
- Humble Patti A. bought 24,875 shares at $10.05 (β$249.99K) on Sep 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 26, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 26, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Aug 24, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Aug 6, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $249.96M (prior year $176.06M) (+42.0% vs Jun 30, 2025)
- Net income: $7.87M (prior year $5.99M) (+31.4% vs Jun 30, 2025)
- Diluted EPS: $0.07 (prior year $0.05) (+40.0% vs Jun 30, 2025)
Aug 5, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 31, 2026 Β· Form SCHEDULE 13G β Passive stake (13G)
Passive stake (13G) β an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 17, 2026 Β· Form 144 β Planned insider sale
Notice of proposed sale (Form 144) β an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 14, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 30, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
- Item 2.03 β Took on a new material debt or financial obligation.
- Item 8.01 β Reported other events the company considers important.
Jun 22, 2026 Β· Form 11-K β Annual report for an employee stock plan
Annual report for an employee stock plan
Things to know before you trade ECVT
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Feb 26, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.22% (largest 2.5%).
- Liquidity: about 1.12M shares (β$11.54M) trade per day on average.
- 52-week position: $10.28 vs a range of $7.41β$15.09 (37% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 8 sales; latest: Patti A. Humble bought 24,875 shares on Sep 10, 2026.
- Latest filings: 8-K Aug 24, 2026; 10-Q Aug 6, 2026; 8-K Aug 5, 2026.
- Share count: 109.47M shares outstanding (Jul 31, 2026), -4.3% vs a year earlier β the company has been reducing its share count.
- Listing: NYSE Β· industry: Chemicals & Allied Products.
ECVT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 10.16 | 10.29 | 10.06 | 10.28 | 1.69M |
| Oct 15, 2026 | 9.90 | 10.19 | 9.76 | 10.17 | 1.76M |
| Oct 14, 2026 | 9.98 | 10.08 | 9.86 | 9.92 | 945.40K |
| Oct 13, 2026 | 9.97 | 10.13 | 9.90 | 10.08 | 694.20K |
| Oct 12, 2026 | 10.09 | 10.09 | 9.91 | 9.92 | 848.50K |
| Oct 9, 2026 | 10.18 | 10.23 | 10.05 | 10.05 | 674.50K |
| Oct 8, 2026 | 10.35 | 10.44 | 10.12 | 10.21 | 1.60M |
| Oct 7, 2026 | 10.34 | 10.38 | 10.23 | 10.31 | 1.10M |
| Oct 6, 2026 | 10.46 | 10.50 | 10.31 | 10.37 | 1.45M |
| Oct 5, 2026 | 10.12 | 10.43 | 10.09 | 10.37 | 1.03M |
| Oct 2, 2026 | 10.06 | 10.19 | 10.03 | 10.12 | 1.08M |
| Oct 1, 2026 | 9.76 | 10.02 | 9.56 | 9.96 | 1.18M |
| Sep 30, 2026 | 9.85 | 9.90 | 9.74 | 9.83 | 1.08M |
| Sep 29, 2026 | 10.00 | 10.05 | 9.80 | 9.80 | 1.25M |
| Sep 28, 2026 | 10.09 | 10.15 | 9.93 | 10.04 | 917.50K |
| Sep 25, 2026 | 10.15 | 10.26 | 10.08 | 10.14 | 1.01M |
| Sep 24, 2026 | 10.35 | 10.41 | 10.12 | 10.14 | 860.80K |
| Sep 23, 2026 | 10.45 | 10.56 | 10.32 | 10.33 | 981.30K |
| Sep 22, 2026 | 10.44 | 10.60 | 10.31 | 10.45 | 1.13M |
| Sep 21, 2026 | 10.48 | 10.49 | 10.35 | 10.39 | 1.16M |
About Ecovyst
Ecovyst (ECVT) is listed on the NYSE and classified by the SEC under βChemicals & Allied Productsβ. Its business address is in WAYNE, PA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1708035.
ECVT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Donald L. Althoff | Director | Feb 5, 2026 |
| Kurt Bitting | See Remarks | Mar 16, 2026 |
| David A. Bradley | Director | Feb 5, 2026 |
| Bryan K. Brown | Director | Feb 5, 2026 |
| Anna C Catalano | Director | Feb 5, 2026 |
| Kevin Michael Fogarty | Director | Feb 5, 2026 |
| Patti A. Humble | Director | Sep 14, 2026 |
| Sarah Lorance | Director | Jun 3, 2026 |
| Susan F Ward | Director | Feb 5, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Laurie Bergman | See Remarks | Aug 26, 2026 |
| Kurt Bitting | See Remarks | Mar 16, 2026 |
| Michael Feehan | See Remarks | Mar 6, 2026 |
| Joseph S. Koscinski | See Remarks | Mar 6, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 10, 2026 | Patti A. Humble | Buy | 24,875 | $10.05 |
| Sep 10, 2026 | Patti A. Humble | Buy | 24,875 | $10.05 |
| Sep 10, 2026 | Patti A. Humble | Buy | 24,875 | $10.05 |
| Sep 10, 2026 | Patti A. Humble | Buy | 24,875 | $10.05 |
| Jun 2, 2026 | Sarah Lorance | Sale | 8,450 | $13.33 |
| Jun 2, 2026 | Sarah Lorance | Sale | 8,450 | $13.33 |
| Jun 2, 2026 | Sarah Lorance | Sale | 8,450 | $13.33 |
| Jun 2, 2026 | Sarah Lorance | Sale | 8,450 | $13.33 |
| Nov 7, 2025 | Susan F Ward | Sale | 15,000 | $8.40 |
| Nov 7, 2025 | Susan F Ward | Sale | 15,000 | $8.40 |
| Nov 7, 2025 | Susan F Ward | Sale | 15,000 | $8.40 |
| Nov 7, 2025 | Susan F Ward | Sale | 15,000 | $8.40 |
ECVT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $723.51M | $-71.13M | -0.61 | $140.31M |
| Dec 31, 2024 | $598.29M | $-6.65M | -0.06 | $149.89M |
| Dec 31, 2023 | $584.85M | $71.15M | 0.60 | $137.60M |
| Dec 31, 2022 | $820.16M | $73.70M | 0.55 | $186.61M |
| Dec 31, 2021 | $611.20M | $-139.95M | -1.02 | $129.92M |
Latest balance sheet: total assets $1.42B, total liabilities $833.76M, cash $87.76M (as of Jun 30, 2026).
ECVT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $11.45 |
| May 5, 2026 | 8-K Item 2.02 (results) | $14.73 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $11.45 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $7.84 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $8.20 |
| May 1, 2025 | 8-K Item 2.02 (results) | $6.19 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $6.93 |
| Oct 31, 2024 | 8-K Item 2.02 (results) | $6.66 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | β |
| May 2, 2024 | 8-K Item 2.02 (results) | β |
| Feb 28, 2024 | 8-K Item 2.02 (results) | β |
| Nov 2, 2023 | 8-K Item 2.02 (results) | β |
Related stocks Β· Chemicals & Allied Products
Solstice Advanced Materials (SOLS)Olin (OLN)Fmc (FMC)Balchem (BCPC)Perimeter Solutions (PRM)Chemours (CC)Huntsman (HUN)Innospec (IOSP)Ingevity (NGVT)Standard Lithium (SLI)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ECVT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.